^○Kiyotaka Yoh¹, Melissa Johnson², Alexander Spira³, Rebecca Heist⁴, Aaron Lisberg⁵, Jonathan Greenberg⁶, Penny Phillips⁶, Lan Lan⁶, Wen Gu⁶, Yong Zhang⁶, Jacob Sands⁷ (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Sarah Cannon Research Institute, Tennessee Oncology, PLLC/OneOncology, Nashville,TN/United States of America, 3.Virginia Cancer Specialists and US Oncology Research, Fairfax, VA/United States of America, 4.Massachusetts General Hospital, Boston, MA/United States of America, 5.University of California Los Angeles, Los Angeles, CA/United States of America, 6.Daiichi Sankyo, Inc., Basking Ridge, NJ/United States of America, 7.Dana-Farber Cancer Institute, Boston, MA/United States of America)

^○Hidehito Horinouchi¹, J.W. Goldman², F. Moiseenko³, I. Cicin⁴, E. Filippova⁵, J. Bar⁶, P. Tomasini⁷, C. Ocampo⁸, D. Sullivan⁸, D. Maag⁸, M. Motwani⁸, J. Jin⁸, D.R. Camidge⁹ (1.National Cancer Center Hospital, 2.David Geffen School of Medicine at UCLA, Los Angeles, CA/United States of America, 3.St. Petersburg City Cancer Center, St. Petersburg/Russian Federation, 4.Trakya University Medical Center, Edirne/Turkey, 5.Center of Palliative Medicine De Vita, St. Petersburg/Russian Federation, 6.Sheba Medical Center, Ramat Gan/lsrael, 7.Aix Marseille Univ, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, Marseille/France, 8.AbbVie, Inc., North Chicago, IL/United States of America, 9.University of Colorado Cancer Center, Aurora, CO/United States of America)

^○Koichi Goto¹, Egbert F. Smit², Bob T. Li³, Julian Mazieres⁴, David Planchard⁵, Kazuhiko Nakagawa⁶, Luis Paz-Ares⁷, Silvia Novello⁸, James Chih-Hsin Yang⁹, Myung-Ju Ahn¹⁰, Geoffrey Liu¹¹, Kenneth O’Byrne¹², Mehreteab Aregay¹³, Ryota Shiga¹³, Kapil Saxena¹³, Kaline Pereira¹³, Gerold Meinhardt¹³, Pasi A. Janne¹⁴ (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Netherlands Cancer Institute, Amsterdam, Netherlands, 3.Memorial Sloan Kettering Cancer Center, New York, NY, USA, 4.Institut Universitaire du Cancer, Toulouse, France, 5.Gustave Roussy, Villejuif, France, 6.Kindai University Hospital, Osaka, Japan, 7.Hospital Universitario 12 de Octubre, Madrid, Spain, 8.University of Turin, AOU San Luigi-Orbassano (TO), Orbassano, Italy, 9.National Taiwan University Cancer Center, Taipei, Taiwan, 10.Samsung Medical Center, Seoul, South Korea, 11.Princess Margaret Cancer Centre, Toronto, ON, Canada, 12.Princess Alexandra Hospital, Brisbane, QLD, Australia, 13.Daiichi Sankyo, Inc., Basking Ridge, NJ, USA, 14.Dana-Farber Cancer Institute and Belfer Center for Applied Cancer Science, Boston, MA, USA)

^○Kohei Shitara¹, Haeseong Park², Tanios Bekaii-Saab³, Sunnie S. Kim⁴, Suneel Kamath⁵, Michael J. Pishvaian⁶, Christopher Chen⁷, David B. Zhen⁸, Joal Mayor⁹, Qianwen Tan⁹, John H. Strickler¹⁰ (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Washington University School of Medicine, 3.Mayo Clinic, 4.University of Colorado Cancer Center, 5.Cleveland Clinic, 6.Johns Hopkins Kimmel Cancer Center, 7.Stanford University School of Medicine, 8.University of Washington, 9.Seagen Inc, 10.Duke University Medical Center)

^○Hitomi Sakai¹, Yoshio Itani², Yoichi Kobayashi³, Mikiko Sato⁴, Kazuto Tasaki⁵, Shoji Nagao⁶, Masayuki Futagami⁷, Makoto Yamamoto⁸, Tetsutaro Hamano⁹, Nao Suzuki¹⁰, Yoshio Yoshida¹¹ (1.Advanced Cancer Translational Institute (ACT), Showa University, 2.Yao Municipal Hospital Palliative Care Center, 3.Department of Obstetrics and Gynecology, Kyorin University, Faculty of Medicine, 4.Department of Obstetrics and Gynecology, Nihon University School of Medicine, 5.Department of Obstetrics and Gynecology, Kurume University School of Medicine, 6.Hyogo Prefectural Cancer Center, 7.Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 8.Japanese Red Cross Fukui Hospital, 9.P4 Statistics co. ltd., 10.Department of Obstetrics and Gynecology, St. Marianna University School of Medicine Hospital, 11.Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui)

^○Yoshitaka Zenke¹, Keiju Aokage², Tsuboi Masahiro², Horinouchi Hidehito³, Nakamura Naoki⁴, Ishikura Satoshi⁵, Nishikawa Hiroyoshi⁶, Kumagai Shogo⁶, Koyama Shohei⁶, Kanato Keisuke⁷, Kataoka Tomoko⁷, Wakabayashi Masashi⁷, Sekino Yuta⁷, Fukutani Miki⁸, Chen-Yoshikawa Toyofumi⁹, Okada Morihito¹⁰, Takahama Makoto¹¹, Suzuki Kenji¹², Ohe Yuichiro³, Watabnabe Shun-Ichi¹³ (1.Department of Thoracic Oncology, National Cancer Center Hospital East, 2.Division of Thoracic Surgery, National Cancer Center Hospital East, 3.Division of Thoracic Oncology, National Cancer Center Hospital, 4.Department of Radiology, St. Marianna University School of Medicine, 5.Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 6.Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, 7.JCOG Data Center/Operations Office, National Cancer Center Hospital, 8.Clinical Research Support Office, National Cancer Center Hospital East, 9.Department of Thoracic Surgery, Nagoya University School of Medicine, 10.Department of Surgical Oncology, Hiroshima University, 11.Department of General Thoracic Surgery, Osaka City General Hospital, 12.Department of General Thoracic Surgery, Juntendo University School of Medicine, 13.Division of Thoracic Surgery, National Cancer Center Hospital)